Your browser doesn't support javascript.
loading
Evidence for a direct effect of the NAD+ precursor acipimox on muscle mitochondrial function in humans.
van de Weijer, Tineke; Phielix, Esther; Bilet, Lena; Williams, Evan G; Ropelle, Eduardo R; Bierwagen, Alessandra; Livingstone, Roshan; Nowotny, Peter; Sparks, Lauren M; Paglialunga, Sabina; Szendroedi, Julia; Havekes, Bas; Moullan, Norman; Pirinen, Eija; Hwang, Jong-Hee; Schrauwen-Hinderling, Vera B; Hesselink, Matthijs K C; Auwerx, Johan; Roden, Michael; Schrauwen, Patrick.
Afiliação
  • van de Weijer T; Department of Human Biology, Maastricht University Medical Center, Maastricht, the Netherlands School for Nutrition, Toxicology and Metabolism, Maastricht University Medical Center, Maastricht, the Netherlands.
  • Phielix E; Department of Human Biology, Maastricht University Medical Center, Maastricht, the Netherlands Institute for Clinical Diabetology, German Diabetes Center, Düsseldorf, Germany.
  • Bilet L; Department of Human Biology, Maastricht University Medical Center, Maastricht, the Netherlands School for Nutrition, Toxicology and Metabolism, Maastricht University Medical Center, Maastricht, the Netherlands.
  • Williams EG; Laboratory of Integrative and Systems Physiology, École Polytechnique Fédérale de Lausanne, Lausanne, Switzerland.
  • Ropelle ER; Laboratory of Integrative and Systems Physiology, École Polytechnique Fédérale de Lausanne, Lausanne, Switzerland.
  • Bierwagen A; Institute for Clinical Diabetology, German Diabetes Center, Düsseldorf, Germany.
  • Livingstone R; Institute for Clinical Diabetology, German Diabetes Center, Düsseldorf, Germany.
  • Nowotny P; Institute for Clinical Diabetology, German Diabetes Center, Düsseldorf, Germany.
  • Sparks LM; Department of Human Biology, Maastricht University Medical Center, Maastricht, the Netherlands School for Nutrition, Toxicology and Metabolism, Maastricht University Medical Center, Maastricht, the Netherlands.
  • Paglialunga S; Department of Human Biology, Maastricht University Medical Center, Maastricht, the Netherlands School for Nutrition, Toxicology and Metabolism, Maastricht University Medical Center, Maastricht, the Netherlands.
  • Szendroedi J; Institute for Clinical Diabetology, German Diabetes Center, Düsseldorf, Germany Department of Endocrinology and Diabetology, Medical Faculty, Heinrich Heine University, University Hospital Düsseldorf, Düsseldorf, Germany.
  • Havekes B; School for Nutrition, Toxicology and Metabolism, Maastricht University Medical Center, Maastricht, the Netherlands Department of Internal Medicine, Maastricht University Medical Center, Maastricht, the Netherlands.
  • Moullan N; Laboratory of Integrative and Systems Physiology, École Polytechnique Fédérale de Lausanne, Lausanne, Switzerland.
  • Pirinen E; Laboratory of Integrative and Systems Physiology, École Polytechnique Fédérale de Lausanne, Lausanne, Switzerland Biotechnology and Molecular Medicine, A. I. Virtanen Institute for Molecular Sciences, Biocenter Kuopio, University of Eastern Finland, Kuopio, Finland.
  • Hwang JH; Institute for Clinical Diabetology, German Diabetes Center, Düsseldorf, Germany.
  • Schrauwen-Hinderling VB; School for Nutrition, Toxicology and Metabolism, Maastricht University Medical Center, Maastricht, the Netherlands Department of Radiology, Maastricht University Medical Center, Maastricht, the Netherlands.
  • Hesselink MK; School for Nutrition, Toxicology and Metabolism, Maastricht University Medical Center, Maastricht, the Netherlands Department of Human Movement Sciences, Maastricht University Medical Center, Maastricht, the Netherlands.
  • Auwerx J; Laboratory of Integrative and Systems Physiology, École Polytechnique Fédérale de Lausanne, Lausanne, Switzerland.
  • Roden M; Institute for Clinical Diabetology, German Diabetes Center, Düsseldorf, Germany Department of Endocrinology and Diabetology, Medical Faculty, Heinrich Heine University, University Hospital Düsseldorf, Düsseldorf, Germany German Center for Diabetes Research, Partner Düsseldorf, Düsseldorf, Germany mi
  • Schrauwen P; Department of Human Biology, Maastricht University Medical Center, Maastricht, the Netherlands School for Nutrition, Toxicology and Metabolism, Maastricht University Medical Center, Maastricht, the Netherlands p.schrauwen@maastrichtuniversity.nl.
Diabetes ; 64(4): 1193-201, 2015 Apr.
Article em En | MEDLINE | ID: mdl-25352640

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pirazinas / Músculo Esquelético / Diabetes Mellitus Tipo 2 / Mitocôndrias Musculares / Hipolipemiantes Tipo de estudo: Clinical_trials Limite: Female / Humans / Male / Middle aged Idioma: En Revista: Diabetes Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Holanda País de publicação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pirazinas / Músculo Esquelético / Diabetes Mellitus Tipo 2 / Mitocôndrias Musculares / Hipolipemiantes Tipo de estudo: Clinical_trials Limite: Female / Humans / Male / Middle aged Idioma: En Revista: Diabetes Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Holanda País de publicação: Estados Unidos